Europe Robotic Neurosurgery Market: Analysis and Forecast, 2025-2035
Description
Introduction to Europe Robotic Neurosurgery Market
The Europe robotic neurosurgery market is projected to reach $585.3 million by 2035 and estimated $93.1 million in 2024, growing at a CAGR of 17.83% during the forecast period 2025-2035. The increasing prevalence of neurological disorders and the resulting need for sophisticated surgical techniques are major factors driving the growth of the robotic neurosurgery market in Asia-Pacific. Advances in AI-enabled guidance, real-time imagery integration, and precision robots are increasing application areas and enhancing results. Adoption is accelerating due to a regional shift towards minimally invasive techniques that reduce complications and shorten recovery times.
Market Introduction
The market for robotic neurosurgery in Europe is expected to increase steadily as medical professionals use more sophisticated technology to treat the growing number of neurological conditions. Surgeons can execute intricate treatments like deep brain stimulation (DBS), epilepsy mapping, and tumour resections with less tissue damage and more accuracy because to robotic systems' unmatched precision. Europe's well-established healthcare system, favourable payment policies, and increasing focus on minimally invasive procedures have all contributed to the continent's thriving industry.
The region's ageing population and the rise in neurological illnesses that goes along with it are major factors driving the demand for advanced surgical procedures. In addition to improving patient outcomes and reducing recovery periods, technological advancements like haptic feedback, real-time imaging integration, and AI-enhanced navigation are expanding the range of robotic applications. Prominent regional and international companies, including as Monteris Medical, Renishaw, Zimmer Biomet, and Medtronic, are actively working with academic institutions to improve workflow integration and demonstrate clinical efficacy.
High acquisition and maintenance costs, strict EU Medical Device Regulation (MDR) criteria for CE marking, and the demand for specialised surgeon training are some of the challenges facing the business despite its strong pace. However, it is anticipated that these difficulties will be lessened by continued investments in R&D and expanding surgical centre accreditation programs. The market for robotic neurosurgery in Europe is therefore expected to develop quickly because to innovation, harmonised regulations, and a shared drive for more precise, patient-centered care.
Market Segmentation
Segmentation 1: by Region
Europe
U.K.
Germany
France
Italy
Spain
Rest-of-Europe
Europe Robotic Neurosurgery Market Trends, Drivers and Challenges
Market Trends
Integration of AI-driven imaging and navigation platforms for enhanced precision and reduced errors
Growth of multi-modal systems combining robotics with augmented reality and haptic feedback
Increasing use of frameless stereotactic robots (e.g., ROSA) for minimally invasive neurosurgical procedures
Miniaturization and modular robotic arms enabling flexible deployment in diverse OR environments
Key Drivers
Rising prevalence of neurological disorders (e.g., Parkinson’s, epilepsy, brain tumors)
Favorable reimbursement policies and expanding healthcare budgets
Clinical evidence showing reduced operative time, improved accuracy, and better patient outcomes
Growth of specialized neurosurgical centers and training programs
Major Challenges
High acquisition and maintenance costs limiting access for smaller hospitals
Steep learning curves and shortage of trained neurosurgical robotics teams
Regulatory and CE-marking complexities delaying market entry
Integration hurdles with legacy IT systems and cybersecurity concerns
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.
Some prominent names in the market include:
Brainlab AG
Renishaw plc
Medtronic plc.
*PDF email from publisher allows for 1-3 users, with permission to print*
Please Note: It will take 1-5 business days to complete the report upon order confirmation.
The Europe robotic neurosurgery market is projected to reach $585.3 million by 2035 and estimated $93.1 million in 2024, growing at a CAGR of 17.83% during the forecast period 2025-2035. The increasing prevalence of neurological disorders and the resulting need for sophisticated surgical techniques are major factors driving the growth of the robotic neurosurgery market in Asia-Pacific. Advances in AI-enabled guidance, real-time imagery integration, and precision robots are increasing application areas and enhancing results. Adoption is accelerating due to a regional shift towards minimally invasive techniques that reduce complications and shorten recovery times.
Market Introduction
The market for robotic neurosurgery in Europe is expected to increase steadily as medical professionals use more sophisticated technology to treat the growing number of neurological conditions. Surgeons can execute intricate treatments like deep brain stimulation (DBS), epilepsy mapping, and tumour resections with less tissue damage and more accuracy because to robotic systems' unmatched precision. Europe's well-established healthcare system, favourable payment policies, and increasing focus on minimally invasive procedures have all contributed to the continent's thriving industry.
The region's ageing population and the rise in neurological illnesses that goes along with it are major factors driving the demand for advanced surgical procedures. In addition to improving patient outcomes and reducing recovery periods, technological advancements like haptic feedback, real-time imaging integration, and AI-enhanced navigation are expanding the range of robotic applications. Prominent regional and international companies, including as Monteris Medical, Renishaw, Zimmer Biomet, and Medtronic, are actively working with academic institutions to improve workflow integration and demonstrate clinical efficacy.
High acquisition and maintenance costs, strict EU Medical Device Regulation (MDR) criteria for CE marking, and the demand for specialised surgeon training are some of the challenges facing the business despite its strong pace. However, it is anticipated that these difficulties will be lessened by continued investments in R&D and expanding surgical centre accreditation programs. The market for robotic neurosurgery in Europe is therefore expected to develop quickly because to innovation, harmonised regulations, and a shared drive for more precise, patient-centered care.
Market Segmentation
Segmentation 1: by Region
Europe
U.K.
Germany
France
Italy
Spain
Rest-of-Europe
Europe Robotic Neurosurgery Market Trends, Drivers and Challenges
Market Trends
Integration of AI-driven imaging and navigation platforms for enhanced precision and reduced errors
Growth of multi-modal systems combining robotics with augmented reality and haptic feedback
Increasing use of frameless stereotactic robots (e.g., ROSA) for minimally invasive neurosurgical procedures
Miniaturization and modular robotic arms enabling flexible deployment in diverse OR environments
Key Drivers
Rising prevalence of neurological disorders (e.g., Parkinson’s, epilepsy, brain tumors)
Favorable reimbursement policies and expanding healthcare budgets
Clinical evidence showing reduced operative time, improved accuracy, and better patient outcomes
Growth of specialized neurosurgical centers and training programs
Major Challenges
High acquisition and maintenance costs limiting access for smaller hospitals
Steep learning curves and shortage of trained neurosurgical robotics teams
Regulatory and CE-marking complexities delaying market entry
Integration hurdles with legacy IT systems and cybersecurity concerns
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.
Some prominent names in the market include:
Brainlab AG
Renishaw plc
Medtronic plc.
*PDF email from publisher allows for 1-3 users, with permission to print*
Please Note: It will take 1-5 business days to complete the report upon order confirmation.
Table of Contents
76 Pages
- Executive Summary
- Scope and Definition
- 1 Europe Robotic Neurosurgery Market: Industry Outlook
- 1.1 Trends: Current and Future Impact Assessment
- 1.1.1 Increasing Adoption of Robotic Neurosurgery Procedures
- 1.1.2 Significant Number of Collaborations among Market Players
- 1.1.3 Growing Number of Product Launch and Regulatory Approvals
- 1.2 Supply Chain Overview
- 1.3 Regulatory Framework
- 1.3.1 European Union (EU)
- 1.3.2 U.K.
- 1.4 Pricing Analysis
- 1.5 Funding Scenario
- 1.6 Market Dynamics
- 1.6.1 Market Drivers
- 1.6.1.1 Advantages of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
- 1.6.1.2 Rising Prevalence of Neurological Disorders
- 1.6.1.3 Continuous Technological Advancements in Robotic Neurosurgery
- 1.6.2 Market Restraints
- 1.6.2.1 High Cost of Investment
- 1.6.2.2 Lack of Skilled Professionals
- 1.6.3 Market Opportunities
- 1.6.3.1 Development of Long-Distance Teleoperated Surgical Robotic Systems
- 2 Robotic Neurosurgery Market (by Region), $Million, 2023-2035
- 2.1 Regional Summary
- 2.2 Europe
- 2.2.1 Regional Overview
- 2.2.2 Driving Factors for Market Growth
- 2.2.3 Factors Challenging the Market
- 2.2.4 Procedure Volume
- 2.2.5 Germany
- 2.2.6 Spain
- 2.2.7 U.K.
- 2.2.8 Rest-of-Europe
- 3 Markets - Product Profiles
- 3.1 Renishaw plc
- 3.1.1 Product Overview
- 3.1.2 Launch Year
- 3.1.3 Key Features
- 3.1.4 Key Parameter
- 3.1.5 Installed Base
- 3.1.6 Unit Sold
- 3.2 Zimmer Biomet Holdings, Inc.
- 3.2.1 Product Overview
- 3.2.2 Launch Year
- 3.2.3 Key Features
- 3.2.4 Key Parameter
- 3.2.5 Installed Base
- 3.2.6 Unit Sold
- 4 Markets - Competitive Benchmarking & Company Profiles
- 4.1 Product Benchmarking
- 4.2 Key Strategies and Development
- 4.3 Company Profiles
- 4.3.1 Brainlab AG
- 4.3.1.1 Overview
- 4.3.1.2 Top Products/Product Portfolio
- 4.3.1.3 Top Competitors
- 4.3.1.4 Target Customers
- 4.3.1.5 Key Personal
- 4.3.1.6 Analyst View
- 4.3.2 Renishaw plc
- 4.3.2.1 Overview
- 4.3.2.2 Top Products/Product Portfolio
- 4.3.2.3 Top Competitors
- 4.3.2.4 Target Customers
- 4.3.2.5 Key Personal
- 4.3.2.6 Analyst View
- 4.3.3 Medtronic plc
- 4.3.3.1 Overview
- 4.3.3.2 Top Products/Product Portfolio
- 4.3.3.3 Top Competitors
- 4.3.3.4 Target Customers
- 4.3.3.5 Key Personal
- 4.3.3.6 Analyst View
- 5 Research Methodology
- 5.1 Data Sources
- 5.1.1 Primary Data Sources
- 5.1.2 Secondary Data Sources
- 5.1.3 Data Triangulation
- 5.2 Market Estimation and Forecast
- List of Figures
- Figure 1: Europe Robotic Neurosurgery Market (by Scenario), $Million, 2024, 2028, and 2035
- Figure 2: Robotic Neurosurgery Market, $Million, 2023 and 2035
- Figure 3: Europe Robotic Neurosurgery Market (by Product Type), $Million, 2023, 2028, and 2035
- Figure 4: Robotic Neurosurgery Literature Published, January 2015 to April 2025
- Figure 5: Supply Chain and Risks within the Supply Chain
- Figure 6: EU Classification
- Figure 7: NHS Classification
- Figure 8: Impact Analysis of Market Navigating Factors, 2024-2035
- Figure 9: Global Incidences of Neurological Disorders, Thousands, 2018-2021
- Figure 10: Global Prevalence of Neurological Disorders (by Type of Neurological Disease), Thousands, 1990-2019
- Figure 11: Prevalence of Parkinson's Disease, Region (2016-2021)
- Figure 12: Timeline of the FDA Approvals for Various Robotic Neurosurgery Systems
- Figure 13: Europe Robotic Neurosurgery Market, Procedure Volume, 2023-2035
- Figure 14: Europe Robotic Neurosurgery Market, $Million, 2023-2035
- Figure 15: Europe Robotic Neurosurgery Market, Installed Base, 2023-2035
- Figure 16: Europe Robotic Neurosurgery Market, Unit Sold, 2023-2035
- Figure 17: Incidences of Neurological Disorders in Germany, 2018-2021
- Figure 18: Germany Robotic Neurosurgery Market, Procedure Volume, 2023-2035
- Figure 19: Germany Robotic Neurosurgery Market, $Million, 2023-2035
- Figure 20: Incidences of Neurological Disorders in France, 2018-2021
- Figure 21: France Robotic Neurosurgery Market, Procedure Volume, 2023-2035
- Figure 22: France Robotic Neurosurgery Market, $Million, 2023-2035
- Figure 23: Incidences of Neurological Disorders in Italy, 2018-2021
- Figure 24: Italy Robotic Neurosurgery Market, Procedure Volume, 2023-2035
- Figure 25: Italy Robotic Neurosurgery Market, $Million, 2023-2035
- Figure 26: Incidences of Neurological Disorders in Spain, 2018-2021
- Figure 27: Spain Robotic Neurosurgery Market, Procedure Volume, 2023-2035
- Figure 28: Spain Robotic Neurosurgery Market, $Million, 2023-2035
- Figure 29: Incidences of Neurological Disorders in U.K., 2018-2021
- Figure 30: U.K. Robotic Neurosurgery Market, Procedure Volume, 2023-2035
- Figure 31: U.K. Robotic Neurosurgery Market, $Million, 2023-2035
- Figure 32: Rest-of-Europe Robotic Neurosurgery Market, Procedure Volume, 2023-2035
- Figure 33: Rest-of-Europe Robotic Neurosurgery Market, $Million, 2023-2035
- Figure 34: Strategic Initiatives, January 2022-April 2025
- Figure 35: Data Triangulation
- Figure 36: Top-Down and Bottom-Up Approach
- Figure 37: Assumptions and Limitations
- List of Tables
- Table 1: Market Snapshot
- Table 2: Competitive Landscape Snapshot
- Table 3: Robotic Neurosurgery Market Trend Analysis
- Table 4: Some of the Partnerships and Collaborations in the Robotic Neurosurgery Market
- Table 5: Some of the Product Launch and Regulatory Approvals in the Robotic Neurosurgery Market
- Table 6: Costs of Neurosurgery Robotic Systems
- Table 7: Funding Scenario of Neurosurgery Robotic Systems
- Table 8: Comparison of Robotic Neurosurgical Procedures Over Conventional Open Surgical Procedures
- Table 9: Comparison Between Various Navigation Systems Cost Breakdown of Robotic Neurosurgery Systems
- Table 10: Robotic Neurosurgery Market (by Region), $Million, 2023-2035
- Table 11: Europe Robotic Neurosurgery Market (by Product Type), $Million, 2023-2035
- Table 12: Incidences of Neurological Disorders in Germany, By Disease Type, 2018-2021
- Table 13: Incidences of Neurological Disorders in France, By Disease Type, 2018-2021
- Table 14: Incidences of Neurological Disorders in Italy, By Disease Type, 2018-2021
- Table 15: Incidences of Neurological Disorders in Spain, By Disease Type, 2018-2021
- Table 16: Incidences of Neurological Disorders in U.K., By Disease Type, 2018-2021
- Table 17: Robotic Neurosurgery Market, Product Benchmarking (by Product)
- Table 18: Key Strategies, January 2022-April 2025
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
